Upload Avatar (500 x 500)
Dabing Huang
hdabing@ustc.edu.cn
Chinese, English
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 2019/07 - 2023/10 Postdoctoral: University of Science and Technology of China, Department of Life Sciences and Medicine
  • 2014/09 - 2017/12 PhD in Clinical Medicine: Shandong University
  • 2006/09 - 2009/07 Master's in Geriatric Medicine: Anhui Medical University
  • 2001/09 - 2006/07 Bachelor's in Clinical Medicine: Anhui Medical University
  • Member of the expert database for science and technology project evaluation of the Anhui Provincial Department of Science and Technology
  • Member of the expert database for degree thesis evaluation of the Ministry of Education
  • 2019/12 - Present: Associate Chief Physician, First Affiliated Hospital of University of Science and Technology of China
  • 2018/01 - 2019/11: Attending Physician, First Affiliated Hospital of University of Science and Technology of China
  • 2014/12 - 2017/12: Attending Physician, Anhui Provincial Hospital, Anhui Medical University
  • 2009/07 - 2014/11: Physician, Anhui Provincial Hospital, Anhui Medical University
  • Anhui Provincial Science and Technology Progress Award (2016): Second Prize, Rank 4
  • Anhui Provincial Science and Technology Progress Award (2012): Second Prize, Rank 5
Research on malignant tumor pathogenesis and treatment resistance using organoids and organ-on-a-chip
Molecular mechanisms and clinical applications of non-coding RNA in cancer treatment resistance
Molecular mechanisms and clinical applications of targeted therapy resistance in cancer
Molecular mechanisms and clinical applications of immunotherapy resistance in cancer
  • V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy., Xia Zhou, Sohail Khan, Dabing Huang, Lu Li, 2022
  • LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells., Pu YG, Tan YA, Zang CB, Zhao FF, Cai CF, Kong LS, Deng H, Chao FM, Xia R, Xie MH, Ge FF, Pan YY, Cai SB, Huang DB, 2021
  • Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis., Wang W, Wang Q, Huang DB, Sun QK, Wu SS, Zhao YJ, Jia W, Hu DS, He YF, 2021
  • Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer., Huang D, Wang Y, He Y, Wang G, Wang W, Han X, Sun Y, Lin L, Shan B, Shen G, Cheng M, Bian G, Fang X, Hu S, Pan Y, 2018
  • MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells., Huang D, Bian G, Pan Y, Han X, Sun Y, Wang Y, Shen G, Cheng M, Fang X, Hu S, 2017
Organoids Organ-On-A-Chip Tumor Microenvironment Malignant Tumors Pathogenesis Treatment Resistance Non-Coding Rna Targeted Therapy Immunotherapy Clinical Applications

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.